Cargando…
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
BACKGROUND: Studies disagree on the location of grey matter (GM) atrophy in the multiple sclerosis (MS) brain. AIM: To examine the consistency between FSL, FreeSurfer, SPM for GM atrophy measurement (for volumes, patient/control discrimination, and correlations with cognition). MATERIALS AND METHODS...
Autores principales: | Popescu, Veronica, Schoonheim, Menno M., Versteeg, Adriaan, Chaturvedi, Nimisha, Jonker, Marianne, Xavier de Menezes, Renee, Gallindo Garre, Francisca, Uitdehaag, Bernard M. J., Barkhof, Frederik, Vrenken, Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706325/ https://www.ncbi.nlm.nih.gov/pubmed/26745873 http://dx.doi.org/10.1371/journal.pone.0143942 |
Ejemplares similares
-
Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy
por: Steenwijk, Martijn D., et al.
Publicado: (2017) -
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
por: Amiri, Houshang, et al.
Publicado: (2018) -
Progression of regional grey matter atrophy in multiple sclerosis
por: Eshaghi, Arman, et al.
Publicado: (2018) -
Development and evaluation of a manual segmentation protocol for deep grey matter in multiple sclerosis: Towards accelerated semi-automated references
por: de Sitter, Alexandra, et al.
Publicado: (2021) -
Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2022)